2.62
price up icon0.77%   0.02
after-market After Hours: 2.62
loading
Cronos Group Inc stock is traded at $2.62, with a volume of 718.92K. It is up +0.77% in the last 24 hours and up +1.55% over the past month. Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
See More
Previous Close:
$2.60
Open:
$2.6
24h Volume:
718.92K
Relative Volume:
0.33
Market Cap:
$1.00B
Revenue:
$87.89M
Net Income/Loss:
$-73.96M
P/E Ratio:
-14.22
EPS:
-0.1843
Net Cash Flow:
$-46.26M
1W Performance:
-5.42%
1M Performance:
+1.55%
6M Performance:
+4.80%
1Y Performance:
+29.70%
1-Day Range:
Value
$2.60
$2.685
1-Week Range:
Value
$2.54
$2.74
52-Week Range:
Value
$1.60
$3.43

Cronos Group Inc Stock (CRON) Company Profile

Name
Name
Cronos Group Inc
Name
Phone
(416) 504-0004
Name
Address
4491 CONCESSION RD 12, STAYNER, ON
Name
Employee
459
Name
Twitter
@cronosgroup
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
CRON's Discussions on Twitter

Compare CRON vs TAK, ZTS, HLN, TEVA, UTHR

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
CRON
Cronos Group Inc
2.62 995.52M 87.89M -73.96M -46.26M -0.1843
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
18.22 57.12B 29.85B 776.90M 4.35B 0.2408
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
125.96 53.16B 9.47B 2.67B 2.28B 6.0218
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.47 47.25B 14.54B 2.22B 2.58B 0.4879
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
32.91 37.59B 17.41B 1.43B 1.00B 1.2182
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
490.21 21.85B 3.13B 1.27B 1.12B 26.39

Cronos Group Inc Stock (CRON) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-27-26 Initiated Canaccord Genuity Buy
Nov-02-22 Initiated Bernstein Mkt Perform
Jul-28-22 Upgrade Canaccord Genuity Hold → Buy
May-11-22 Upgrade CIBC Neutral → Sector Outperform
Mar-22-22 Upgrade Barclays Underweight → Equal Weight
Jan-27-22 Upgrade Jefferies Underperform → Hold
Nov-18-21 Resumed BofA Securities Underperform
Apr-28-21 Resumed BofA Securities Underperform
Feb-22-21 Downgrade CIBC Sector Outperform → Neutral
Jun-24-20 Upgrade Raymond James Mkt Perform → Outperform
Apr-27-20 Downgrade Raymond James Outperform → Mkt Perform
Apr-14-20 Downgrade Piper Sandler Overweight → Neutral
Apr-02-20 Downgrade BofA/Merrill Buy → Neutral
Mar-31-20 Downgrade Canaccord Genuity Hold → Sell
Mar-04-20 Upgrade MKM Partners Neutral → Buy
Mar-03-20 Downgrade Stifel Buy → Hold
Oct-18-19 Upgrade Stifel Hold → Buy
Sep-20-19 Initiated MKM Partners Neutral
Sep-05-19 Upgrade BMO Capital Markets Underperform → Market Perform
Aug-13-19 Initiated Piper Jaffray Overweight
Aug-09-19 Upgrade Canaccord Genuity Sell → Hold
Jun-28-19 Initiated Consumer Edge Research Equal Weight
Jun-06-19 Initiated Stifel Hold
Jun-05-19 Upgrade BofA/Merrill Underperform → Buy
Apr-17-19 Initiated BofA/Merrill Underperform
Mar-27-19 Downgrade Canaccord Genuity Hold → Sell
Feb-25-19 Initiated Jefferies Underperform
Jan-18-19 Initiated CIBC Sector Outperform
View All

Cronos Group Inc Stock (CRON) Latest News

pulisher
Mar 03, 2026

Cronos Group Inc. stock falls Tuesday, underperforms market - MarketWatch

Mar 03, 2026
pulisher
Mar 03, 2026

Cronos Group Inc. (CRON) Earns Buy Rating and C$4.50 PT on Scalable Model - Finviz

Mar 03, 2026
pulisher
Mar 02, 2026

CRON Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 02, 2026
pulisher
Mar 01, 2026

11 Best Pot Stocks to Buy According to Hedge Funds - Insider Monkey

Mar 01, 2026
pulisher
Feb 28, 2026

How The Cronos Group (TSX:CRON) Story Is Shifting With New Targets And Execution Risks - Yahoo Finance

Feb 28, 2026
pulisher
Feb 28, 2026

Cronos Group (NASDAQ:CRON) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat

Feb 28, 2026
pulisher
Feb 27, 2026

Cronos Group Inc. (NASDAQ:CRON) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 27, 2026
pulisher
Feb 27, 2026

Decoding Cronos Group Inc (CRON): A Strategic SWOT Insight - GuruFocus

Feb 27, 2026
pulisher
Feb 26, 2026

Cronos Group (NASDAQ:CRON) Posts Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat

Feb 26, 2026
pulisher
Feb 26, 2026

Cronos Group (CRON) officer Jared Kenost reports RSU and share holdings - Stock Titan

Feb 26, 2026
pulisher
Feb 26, 2026

Cronos Group Inc. stock falls Thursday, underperforms market - MarketWatch

Feb 26, 2026
pulisher
Feb 26, 2026

Cronos Group Inc (CRON) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion - GuruFocus

Feb 26, 2026
pulisher
Feb 26, 2026

Cronos Group Q4 Earnings Call Highlights - MarketBeat

Feb 26, 2026
pulisher
Feb 26, 2026

Cronos Group Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Earnings Call Summary | Cronos Group Inc(CRON.CA) Q4 2025 Earnings Conference - 富途牛牛

Feb 26, 2026
pulisher
Feb 26, 2026

Cronos Group sees record revenue in 2025 amidst international expansion - StratCann

Feb 26, 2026
pulisher
Feb 26, 2026

Cronos Group Posts Record 2025 Revenue and Eyes European Cannabis Expansion - TipRanks

Feb 26, 2026
pulisher
Feb 26, 2026

Earnings call transcript: Cronos Group Q4 2025 sees revenue miss, stock down - Investing.com

Feb 26, 2026
pulisher
Feb 26, 2026

Cronos Group Shares Fall After Posting Swing to Q4 Loss, Net Revenue Gain - marketscreener.com

Feb 26, 2026
pulisher
Feb 26, 2026

Cronos Group Swings to Q4 Loss - marketscreener.com

Feb 26, 2026
pulisher
Feb 26, 2026

Earnings Flash (CRON) Cronos Posts Q4 Net Revenue $44.5M - marketscreener.com

Feb 26, 2026
pulisher
Feb 26, 2026

Earnings Flash (CRON) Cronos Group Inc. Reports Q4 Revenue $44.5M, vs. FactSet Est of $38.7M - marketscreener.com

Feb 26, 2026
pulisher
Feb 26, 2026

Cronos stock down as company swings to Q4 loss (CRON:NASDAQ) - Seeking Alpha

Feb 26, 2026
pulisher
Feb 26, 2026

Cronos: Q4 Earnings Snapshot - marketscreener.com

Feb 26, 2026
pulisher
Feb 26, 2026

Cronos Group Reports 2025 Fourth Quarter and Full-Year Results - The Manila Times

Feb 26, 2026
pulisher
Feb 26, 2026

Cronos Group Inc. SEC 10-K Report - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Cronos Group Earnings Review: Q4 Summary - Benzinga

Feb 26, 2026
pulisher
Feb 26, 2026

Cronos Group Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com

Feb 26, 2026
pulisher
Feb 26, 2026

Cronos Group Inc. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2025 - marketscreener.com

Feb 26, 2026
pulisher
Feb 26, 2026

(CRON) Stock Analysis and Trading Signals (CRON:CA) - Stock Traders Daily

Feb 26, 2026
pulisher
Feb 26, 2026

Insights into Cronos Group Q4 Earnings - Sahm

Feb 26, 2026
pulisher
Feb 25, 2026

Cronos: Fourth Quarter Financial Overview - Bitget

Feb 25, 2026
pulisher
Feb 25, 2026

Top Cannabis Stocks Worth WatchingFebruary 25th - MarketBeat

Feb 25, 2026
pulisher
Feb 25, 2026

Cronos Group Q4 earnings preview - MSN

Feb 25, 2026
pulisher
Feb 25, 2026

Cronos earnings up next as vape push meets profitability test By Investing.com - Investing.com UK

Feb 25, 2026
pulisher
Feb 25, 2026

Cronos earnings up next as vape push meets profitability test - Investing.com

Feb 25, 2026
pulisher
Feb 25, 2026

Cronos: Geographic Expansion Backed By A Strong Balance Sheet (NASDAQ:CRON) - Seeking Alpha

Feb 25, 2026
pulisher
Feb 24, 2026

Cronos Group (CRON) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan

Feb 24, 2026
pulisher
Feb 24, 2026

Cronos Group Inc. stock rises Tuesday, outperforms market - MarketWatch

Feb 24, 2026
pulisher
Feb 24, 2026

Cronos Group (TSE:CRON) PT Set at C$4.50 by TD Securities - MarketBeat

Feb 24, 2026
pulisher
Feb 24, 2026

Cronos Group Inc. (NASDAQ:CRON) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

Feb 24, 2026
pulisher
Feb 24, 2026

Cronos Group Inc expected to post earnings of 1 cent a shareEarnings Preview - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

TD Cowen Initiates Cronos Group at Buy With CA$4.50 Price Target - marketscreener.com

Feb 24, 2026
pulisher
Feb 23, 2026

Cronos Group Inc. stock falls Monday, underperforms market - MarketWatch

Feb 23, 2026
pulisher
Feb 23, 2026

Best Cannabis Stocks To Follow TodayFebruary 22nd - MarketBeat

Feb 23, 2026
pulisher
Feb 23, 2026

(CRON) Stock Trading Blueprint (CRON:CA) - Stock Traders Daily

Feb 23, 2026
pulisher
Feb 23, 2026

Hillsdale Investment Management Inc. Grows Stock Holdings in Cronos Group Inc. $CRON - MarketBeat

Feb 23, 2026
pulisher
Feb 22, 2026

CRON (Cronos Group) Cash From Other Investing Activities : $-10.4 Mil (TTM As of Sep. 2025) - GuruFocus

Feb 22, 2026
pulisher
Feb 21, 2026

Growth Report: Will Cronos Group Inc benefit from seasonalityJuly 2025 Retail & Technical Pattern Based Buy Signals - baoquankhu1.vn

Feb 21, 2026
pulisher
Feb 21, 2026

CRON (Cronos Group) YoY Rev. per Sh. Growth : 5.62% (As of Sep. 2025) - GuruFocus

Feb 21, 2026
pulisher
Feb 21, 2026

CRON (Cronos Group) Sale Of Investment : $-1.3 Mil (TTM As of Sep. 2025) - GuruFocus

Feb 21, 2026

Cronos Group Inc Stock (CRON) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
drug_manufacturers_specialty_generic RDY
$14.28
price up icon 0.21%
$24.44
price down icon 1.77%
drug_manufacturers_specialty_generic RGC
$25.45
price up icon 6.09%
$133.44
price up icon 1.75%
$14.71
price down icon 1.21%
$490.21
price down icon 1.69%
Cap:     |  Volume (24h):